Ziegengeist JL, Tan AR. A Clinical Review of Subcutaneous Trastuzumab and the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in the Treatment of HER2-Positive Breast Cancer. Clin Breast Cancer 2024 Oct 9:S1526-8209(24)00283.
PMID: 39567339